$CTIX Cellceutix Corp. CTIX Company Overview
Cellceutix Corp. CTIX Current Price and Quotes
Last Price 1.83
Previous Close 1.81 Open 1.81
Daily Range 1.85 - 1.81 52wk Range 2.47 - 0.92
Volume 99,934 Dividend N/A
Average Vol (3m) 232,267 Yield N/A
CTIX Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt1=Go!
Last Updated: Monday, November 11, 2013 01:35:31 AM
Cellceutix Corp. CTIX
Company Information
100 Cumming Center
Suite 151-B
Beverly, MA 01915
Website: http://www.cellceutix.com
Phone: 978-633-3623
Email: info@cellceutix.com
Cellceutix Corp. CTIX
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
Cellceutix Corp. CTIX
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 12, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts
Krishna Menon President, CSO
Leo Ehrlich CFO, Interim CEO
Company Directors
Not Available
Company Notes
Formerly=EconoShare, Inc. until 2-2008
Service Providers
Auditor/Accountant
Baker Tilly Virchow Krause
One Penn Plaza
Suite 3000
New York, NY, 10119
United States
Legal Counsel
Not Available
Investor Relations Firm
E Unum Pluribus LLC
Cellceutix Corp. CTIX
CTIX Security Details
Share Structure
Market Value1 $185,779,741 a/o Nov 08, 2013
Shares Outstanding 101,518,984 a/o Sep 17, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 12, 2008
Par Value 0.0001
Shareholders
Shareholders of Record 1,700 a/o Sep 30, 2013
Short Selling Data
Short Interest 111,185 (14%)
Oct 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
West Coast Stock Transfer Inc.
Cellceutix Corp. CTIX Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 1,510 633 1,339 2,001
Sales, General and Admin. 1,473 3,564 4,383 1,363
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,983) (4,197) (5,722) (3,364)
Income From Continuing Operations
Add'l Income/Expense Items - (440) - -
Earnings Before Interest and Tax (2,983) (4,637) (5,722) (3,433)
Interest Expense 241 257 216 -
Earnings Before Tax (3,224) (4,894) (5,938) (3,433)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,224) (4,894) (5,938) (3,433)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,224) (4,894) (5,938) (3,433)
Preferred Stock and Other Adjustments (212) (66) - -
Net Income Applicable to Common Shareholders (3,436) (4,960) (5,938) (3,433)
Cellceutix Corp. CTIX Recent News
Nov 4, 2013 Cellceutix to Pursue Significant Conjuctivitis and Kerititis Ocular Markets With Novel Antibiotic Brilacidin
Oct 29, 2013 Small Cap Stocks in Focus Today are CTIX, CWGL, FNRC and DEWM
Oct 28, 2013 Cellceutix Enters Into New $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
Oct 21, 2013 Cellceutix Structures for Significant Growth in Upcoming Year
Oct 14, 2013 Cellceutix Drug Brilacidin(TM) May Be the Key Antibiotic on the Horizon for Serious Skin Infections; Plans to Start Phase 2b Study in January 2014
Oct 10, 2013 Cellceutix Antibiotic Brilacidin Chosen by Elsevier as "Top Project to Watch" in Infectious Disease
Oct 2, 2013 Cellceutix Completes Final Study to File IND Application for New Psoriasis Drug Prurisol(TM)
Sep 24, 2013 Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial
Sep 16, 2013 Cellceutix Completes Acquisition of PolyMedix Assets, Immediately Plans Brilacidin(TM) Phase 2b Clinical Trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Phase 2 Clinical Trial for Oral Mucositis
Sep 9, 2013 Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets
1
2
next >
CTIX Cellceutix Corp. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTIX/quote
Stock Chart http://www.otcmarkets.com/stock/CTIX/chart
Company Info http://www.otcmarkets.com/stock/CTIX/company-info
Recent News http://www.otcmarkets.com/stock/CTIX/news
Financials http://www.otcmarkets.com/stock/CTIX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTIX/filings
Short Sales http://www.otcmarkets.com/stock/CTIX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTIX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTIX/research
Summary http://finance.yahoo.com/q?s=CTIX
Historical Prices http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTIX
Basic Chart http://finance.yahoo.com/q/bc?s=CTIX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTIX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTIX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTIX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTIX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTIX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTIX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTIX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTIX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTIX
Balance Sheet http://finance.yahoo.com/q/bs?s=CTIX
Cash Flow http://finance.yahoo.com/q/cf?s=CTIX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTIX
Market Watch http://www.marketwatch.com/investing/stock/CTIX
Bloomberg http://www.bloomberg.com/quote/CTIX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTIX
Bussinessweek http://investing.businessweek.com/research/st...icker=CTIX
Barchart http://www.barchart.com/quotes/stocks/CTIX
OTC Short Report http://otcshortreport.com/index.php?index=CTIX
Investopedia http://www.investopedia.com/markets/stocks/CTIX/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Cellceutix Corp. CTIX Current Price and Quotes
Last Price 1.83
Previous Close 1.81 Open 1.81
Daily Range 1.85 - 1.81 52wk Range 2.47 - 0.92
Volume 99,934 Dividend N/A
Average Vol (3m) 232,267 Yield N/A
CTIX Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt1=Go!
Last Updated: Monday, November 11, 2013 01:35:31 AM
Cellceutix Corp. CTIX
Company Information
100 Cumming Center
Suite 151-B
Beverly, MA 01915
Website: http://www.cellceutix.com
Phone: 978-633-3623
Email: info@cellceutix.com
Cellceutix Corp. CTIX
An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers.
Cellceutix Corp. CTIX
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Sep 30, 2013 10-Q
CIK 0001355250
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o May 12, 2008
Incorporated In: NV, USA
Year of Inc. 2005
Employees Not Available
Company Officers/Contacts
Krishna Menon President, CSO
Leo Ehrlich CFO, Interim CEO
Company Directors
Not Available
Company Notes
Formerly=EconoShare, Inc. until 2-2008
Service Providers
Auditor/Accountant
Baker Tilly Virchow Krause
One Penn Plaza
Suite 3000
New York, NY, 10119
United States
Legal Counsel
Not Available
Investor Relations Firm
E Unum Pluribus LLC
Cellceutix Corp. CTIX
CTIX Security Details
Share Structure
Market Value1 $185,779,741 a/o Nov 08, 2013
Shares Outstanding 101,518,984 a/o Sep 17, 2013
Float Not Available
Authorized Shares 300,000,000 a/o May 12, 2008
Par Value 0.0001
Shareholders
Shareholders of Record 1,700 a/o Sep 30, 2013
Short Selling Data
Short Interest 111,185 (14%)
Oct 15, 2013
Significant Failures to Deliver No
Transfer Agent(s)
West Coast Stock Transfer Inc.
Cellceutix Corp. CTIX Financials
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 1,510 633 1,339 2,001
Sales, General and Admin. 1,473 3,564 4,383 1,363
Non-Recurring Items - - - -
Other - - - -
Operating Income (2,983) (4,197) (5,722) (3,364)
Income From Continuing Operations
Add'l Income/Expense Items - (440) - -
Earnings Before Interest and Tax (2,983) (4,637) (5,722) (3,433)
Interest Expense 241 257 216 -
Earnings Before Tax (3,224) (4,894) (5,938) (3,433)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,224) (4,894) (5,938) (3,433)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,224) (4,894) (5,938) (3,433)
Preferred Stock and Other Adjustments (212) (66) - -
Net Income Applicable to Common Shareholders (3,436) (4,960) (5,938) (3,433)
Cellceutix Corp. CTIX Recent News
Nov 4, 2013 Cellceutix to Pursue Significant Conjuctivitis and Kerititis Ocular Markets With Novel Antibiotic Brilacidin
Oct 29, 2013 Small Cap Stocks in Focus Today are CTIX, CWGL, FNRC and DEWM
Oct 28, 2013 Cellceutix Enters Into New $20 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC
Oct 21, 2013 Cellceutix Structures for Significant Growth in Upcoming Year
Oct 14, 2013 Cellceutix Drug Brilacidin(TM) May Be the Key Antibiotic on the Horizon for Serious Skin Infections; Plans to Start Phase 2b Study in January 2014
Oct 10, 2013 Cellceutix Antibiotic Brilacidin Chosen by Elsevier as "Top Project to Watch" in Infectious Disease
Oct 2, 2013 Cellceutix Completes Final Study to File IND Application for New Psoriasis Drug Prurisol(TM)
Sep 24, 2013 Cellceutix Plans Phase 2b Trial of New Antibiotic, Reports Fifth Cohort Complete in Novel Cancer Drug Clinical Trial
Sep 16, 2013 Cellceutix Completes Acquisition of PolyMedix Assets, Immediately Plans Brilacidin(TM) Phase 2b Clinical Trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Phase 2 Clinical Trial for Oral Mucositis
Sep 9, 2013 Cellceutix Acquires PolyMedix Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets
1
2
next >
CTIX Cellceutix Corp. Research DD Guide
Stock Message Board http://investorshangout.com/search?q=CTIX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CTIX/quote
Stock Chart http://www.otcmarkets.com/stock/CTIX/chart
Company Info http://www.otcmarkets.com/stock/CTIX/company-info
Recent News http://www.otcmarkets.com/stock/CTIX/news
Financials http://www.otcmarkets.com/stock/CTIX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CTIX/filings
Short Sales http://www.otcmarkets.com/stock/CTIX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CTIX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CTIX/research
Summary http://finance.yahoo.com/q?s=CTIX
Historical Prices http://finance.yahoo.com/q/hp?s=CTIX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CTIX
Basic Chart http://finance.yahoo.com/q/bc?s=CTIX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CTIX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CTIX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CTIX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CTIX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CTIX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CTIX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CTIX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CTIX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CTIX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CTIX
Balance Sheet http://finance.yahoo.com/q/bs?s=CTIX
Cash Flow http://finance.yahoo.com/q/cf?s=CTIX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CTIX
Market Watch http://www.marketwatch.com/investing/stock/CTIX
Bloomberg http://www.bloomberg.com/quote/CTIX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CTIX
Bussinessweek http://investing.businessweek.com/research/st...icker=CTIX
Barchart http://www.barchart.com/quotes/stocks/CTIX
OTC Short Report http://otcshortreport.com/index.php?index=CTIX
Investopedia http://www.investopedia.com/markets/stocks/CTIX/?wa=0
List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
